Dr. Filip Barinka nimmt am Priority Access Program teil | Miamind

Dr. Filip Barinka nimmt am Priority Access Program teil

Veröffentlicht am 27 November, 2024

Wir freuen uns, bekannt geben zu können, dass Dr. Filip Barinka von der Altersneurologie Gedächtnis-Sprechstunde in Zusammenarbeit mit dem Schweizerischen Neuroradiologischen Institut (SNRI) unserem Priority Access Program als Early Adopter für Alzheimer-Patienten beigetreten ist! 🚀

This innovative program enables selected neuro clinics to utilize our personalized neurostimulator, offering a new frontier in Alzheimer’s care.🧠

Located at the SCNSI - Swiss Clinical Neuro Science Institute (SCNSI) in Zürich, Dr. Barinka’s Praxis specializes in the diagnosis and treatment of neurological conditions, with a focus on:

  • Altersneurologie: Comprehensive care for neurological conditions in older adults, such as gait disorders, Parkinson’s syndrome, epilepsy, and balance issues.
  • Gedächtnis-Sprechstunde: Personalized evaluation and treatment of memory disorders and cognitive deficits, including Alzheimer’s and other forms of dementia.
  • Collaboration with SNRI, providing advanced neuroimaging capabilities for precise diagnostics and therapy planning.

👉 read more here: https://barinka.ch/

With an emphasis on personalized medicine, Dr. Barinka ensures tailored care pathways for each patient, leveraging a network of specialists within and beyond SCNSI for optimal treatment outcomes.

💡 Benefits of our Miamind Neurostimulator:

  • Personalized: Each device is tailored to the patient’s specific MRI data. The therapy plan is created after prescription and target region definition by the expert.
  • Non-invasive: Transcranial stimulation (tCS) offers a safe, non-invasive alternative to treatments with reduced risks, according to current research.
  • Scientifically backed: The benefits of tCS are grounded in extensive research and clinical studies.

Together with Dr. Barinka’s Praxis and the SNRI, we are making strides in improving access to cutting-edge technologies and advancing personalized neurostimulation for Alzheimer’s patients to improve the quality of life for Alzheimer’s patients. A heartfelt thank you to Dr. Barinka and his team for their dedication and partnership in this transformative journey. 🙌

📩 Please contact Bottneuro or reach out to Dr. Filip Barinka, Altersneurologie Gedächtnis-Sprechstunde if you want to learn more about this pilot program.